PositiveToplineResults retweeted
Yakira Capital Calls on $RNA to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing
Questions decision to raise $50M after shares fell apprx 44% at a valuation near 50% of net cash
prnewswire.com/news-releases…
PositiveToplineResults retweeted
Steve Paul back with the inpatient-only approach to psych treatment; do markets never learn?
Also: huge discontinuation rate after short treatment course.
Successful psych drugs enable patients to live normal lives with easy compliance…
$RAPP
Replying to @plainyogurt21
What’s not believable about the maintenance tolerability? Isn’t that always how GLP1 is? And in this case they *reduced* the dose in maintenance.
Kick it off with 80% nausea, a quarter kf the arm discontinues, those who stay are tolerating QW dose, then you cut the dose in half. Why wouldn’t the tol be outstanding in maintnenance?
PositiveToplineResults retweeted
Great work by @Public_Citizen to get the Pfizer MFN contract, seemingly promising the govt a share of revenue from raised prices abroad:
citizen.org/wp-content/uploa…
PositiveToplineResults retweeted
$kzia has been such a nice trading vehicle. I'll probably take a big L soon given the amount I've traded the range
PositiveToplineResults retweeted
so is $CUE no bueno?
PositiveToplineResults retweeted
Couldn't $AZN have found a less bizarre way of distracting attention away from its 12 upcoming pivotal rilvegostomig readouts? $BMY
$XBI
BREAKING: $AZN and $BMY exploring a “megadeal,” per @ft
> $AZN has been exploring a deal to combine with US rival $BMY, which would create one of the world’s biggest pharmaceutical groups.
> Discussions have been held about a tie-up in recent months, according to people familiar with the matter.
> Talks could yield a deal in the near future but may be delayed or fall apart.
> Would be one of the biggest mergers in history.












